Postablation Stimulated Thyroglobulin Level is an Important Predictor of Biochemical Complete Remission after Reoperative Cervical Neck Dissection in Persistent/Recurrent Papillary Thyroid Carcinoma

被引:18
作者
Lang, Brian Hung-Hin [1 ]
Wong, Kai Pun [1 ]
Wan, Koon Yat [2 ]
机构
[1] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China
关键词
EFFICACY; IMPACT;
D O I
10.1245/s10434-012-2624-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The efficacy of reoperative cervical neck dissection (RND) in achieving biochemical complete remission (BCR) (or postreoperation stimulated thyroglobulin [sTg] of < 0.5 ng/mL) remains unclear in persistent/recurrent papillary thyroid carcinoma (PTC). We hypothesized that lower postablation sTg levels would indicate a higher rate of BCR after RND. Our study examined the association between postablation sTg and BCR after one or more RNDs. Of 199 patients who underwent RND, 81 patients were eligible. The postablation sTg levels (a parts per thousand currency sign2 and > 2 ng/mL) were correlated with the postreoperation sTg levels after RNDs. Patients' clinicopathological characteristics, operative findings, and subsequent RNDs were compared between those with BCR after RNDs and those without. Those with postablation sTg levels of a parts per thousand currency sign2 ng/mL had significantly higher BCR rate after the first RND (77.8 vs. 5.6 %, p < 0.001), overall BCR after one or more RNDs (77.8 vs. 9.3 %, p < 0.001), and better 5-year recurrence-free survival after the first RND (80.0 vs. 60.1 %, p = 0.049) than those with postablation sTg levels of > 2 ng/mL. Overall BCR gradually decreased after each subsequent RND. Postablation sTg significantly correlated with postreoperation sTg (rho = 0.509, p < 0.001). After adjusting for the number of metastatic lymph nodes excised at first RND and presence of extranodal extension, postablation sTg of a parts per thousand currency sign 0.2 ng/mL was the only independent factor for BCR after one or more RNDs (odds ratio 37.0, 95 % confidence interval 5.68-250.0, p = 0.001). Only a third of patients who underwent one or more RNDs for persistent/recurrent PTC had BCR afterward. Postablation sTg level was an independent factor for BCR. Completeness of the initial operation is important for the subsequent success of RND.
引用
收藏
页码:653 / 659
页数:7
相关论文
共 17 条
  • [1] Long-Term Efficacy of Lymph Node Reoperation for Persistent Papillary Thyroid Cancer
    Al-Saif, Osama
    Farrar, William B.
    Bloomston, Mark
    Porter, Kyle
    Ringel, Matthew D.
    Kloos, Richard T.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (05) : 2187 - 2194
  • [2] [Anonymous], 1983, CANC INC MORT HONG K
  • [3] Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
    Cooper, David S.
    Doherty, Gerard M.
    Haugen, Bryan R.
    Kloos, Richard T.
    Lee, Stephanie L.
    Mandel, Susan J.
    Mazzaferri, Ernest L.
    McIver, Bryan
    Pacini, Furio
    Schlumberger, Martin
    Sherman, Steven I.
    Steward, David L.
    Tuttle, R. Michael
    [J]. THYROID, 2009, 19 (11) : 1167 - 1214
  • [4] Algorithm for safe and effective reoperative thyroid bed surgery for recurrent/persistent papillary thyroid carcinoma
    Farrag, Tarik Y.
    Agrawal, Nishant
    Sheth, Sheila
    Bettegowda, Chetan
    Ewertz, Marjorie
    Kim, Matthew
    Tufano, Ralph P.
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2007, 29 (12): : 1069 - 1074
  • [5] Reoperative Lymph Node Dissection for Recurrent Papillary Thyroid Cancer and Effect on Serum Thyroglobulin
    Hughes, David T.
    Laird, Amanda M.
    Miller, Barbra S.
    Gauger, Paul G.
    Doherty, Gerard M.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (09) : 2951 - 2957
  • [6] A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later
    Kloos, RT
    Mazzaferri, EL
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (09) : 5047 - 5057
  • [7] Preventable reoperations for persistent and recurrent papillary thyroid carcinoma
    Kouvaraki, MA
    Lee, JE
    Shapiro, SE
    Sherman, SI
    Evans, DB
    [J]. SURGERY, 2004, 136 (06) : 1183 - 1190
  • [8] Staging systems for papillary thyroid carcinoma - A review and comparison
    Lang, Brian Hung-Hin
    Lo, Chung-Yau
    Chan, Wai-Fan
    Lam, King-Yin
    Wan, Koon-Yat
    [J]. ANNALS OF SURGERY, 2007, 245 (03) : 366 - 378
  • [9] Prognostic factors in papillary and follicular thyroid carcinoma: Their implications for cancer staging
    Lang, Brian Hung-Hin
    Lo, Chung-Yau
    Chan, Wai-Fan
    Lam, King-Yin
    Wan, Koon-Yat
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (02) : 730 - 738
  • [10] Impact of Routine Unilateral Central Neck Dissection on Preablative and Postablative Stimulated Thyroglobulin Levels after Total Thyroidectomy in Papillary Thyroid Carcinoma
    Lang, Brian Hung-Hin
    Wong, Kai Pun
    Wan, Koon Yat
    Lo, Chung Yau
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (01) : 60 - 67